Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2016
17th World Conference on Lung Cancer
Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria
Presentation Date(s):- Dec 4 - 7, 2016
- Total Presentations: 2466
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
SC10 - Squamous Cell NSCLC
- Type: Science Session
- Track: Advanced NSCLC
- Presentations: 5
- Moderators:D.R. Gandara
- Coordinates: 12/05/2016, 16:00 - 17:30, Strauss 3
-
+
SC10.02 - EGFR Mutations in Indian Patients with Squamous Cell NSCLC
16:00 - 16:20 | Author(s): K. Prabhash
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P3.02b - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Advanced NSCLC
- Presentations: 126
- Coordinates: 12/07/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P3.02b-007 - Differential Efficacy of Gefitinib in Exon 19 or Exon 21 Mutated Adenocarcinoma Lung
14:30 - 14:30 | Author(s): A. Goel
- Abstract
Loading... -
+
P3.02b-055 - Impact of Pemetrexed Chemotherapy in Exon 19 or Exon 21 Mutated NSCLC
14:30 - 14:30 | Author(s): V.T. Talreja
- Abstract
Loading... -
+
P3.02b-058 - Second-Line Therapy in EGFR Activating Mutation Positive Advanced NSCLC: Analysis from a Randomized Phase III First-Line Trial
14:30 - 14:30 | Author(s): A. Ramaswamy
- Abstract
Loading... -
+
P3.02b-065 - Third Line Therapy in EGFR Positive Advanced Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): N. Pande
- Abstract
Loading... -
+
P3.02b-090 - Pemetrexed versus Gefitinib in EGFR Mutation Positive Lung Cancer: Results of a Phase 3 Study from India
14:30 - 14:30 | Author(s): K. Prabhash
- Abstract
Loading... -
+
P3.02b-094 - Rebiopsy Post Progression in EGFR Mutated Lung Cancer
14:30 - 14:30 | Author(s): A. Chandrasekharan
- Abstract
Loading...